卡维奥林-1表达是切除胰腺管道腺癌的生存和复发模式的预测指标
Yuki Hirose1, Atsushi Oba2, Manabu Takamatsu3
1Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
概括
在胰腺癌细胞中的高卡韦林-1 (Cav1) 预测了更差的生存率和转移. 新辅助化疗 (NAC) 改善了这些患者的治疗结果,这表明Cav1状态有助于个性化胰腺管腺癌 (PDAC) 管理.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 凯沃林-1 (Cav1) 在癌症中具有复杂的作用,在癌细胞 (cCav1) 或癌症相关纤维细胞 (fCav1) 中表达,影响瘤行为.
- 对cCav1和fCav1对胰腺管腺癌 (PDAC) 进展和治疗反应的具体影响仍未完全阐明.
研究的目的:
- 在切除的PDAC中调查cCav1和fCav1的预后意义.
- 确定cCav1和fCav1表达与生存,复发模式以及新辅助化疗 (NAC) 疗效的关联.
主要方法:
- 从615名切除PDAC.患者的组织微阵列分析.
- 在癌细胞 (cCav1) 和癌症相关纤维细胞 (fCav1) 中对Cav1表达的免疫组织化学评估.
- 统计分析以将Cav1表达水平 (高与低) 与临床结果相关联,包括总生存率 (OS),无复发生存率 (RFS) 和对NAC的反应.
主要成果:
- 高cCav1表达 (cCav1高) 与更糟糕的OS和RFS显著相关,是独立的预后因素.
- cCav1高状态预测了早期复发 (<6个月) 和肝转移,被确定为独立预测因素.
- 在接受NAC的患者中,cCav1高状态与改善的生存状况相关,而在cCav1低患者中没有显著的益处.
结论:
- 在PDAC中高cCav1表达与较差的存活率,增加复发率和更高的肝转移概率有关.
- 新辅助化疗显示出一种生存益处,特别是在高cCav1表达的PDAC患者中.
- 评估cCav1状态可以为定制PDAC管理中的个性化治疗策略提供有价值的见解.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...